Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2022 Mar 1.

Published in final edited form as: Eur J Radiol. 2021 Jan 12;136:109539. doi: 10.1016/j.ejrad.2021.109539

Figure 3. — Patients who achieved OR after transarterial radioembolization (TARE) had a significantly longer median OS of 17 months compared with patients that did not who survived a median of 10 months (p=0.03). Response was landmarked at 2 months after TARE, since response status was not known until the first follow-up PET/CT. The analysis includes patients with imaging response assessment who were followed for at least 2 months (n=58).

Figure 3. — Patients who achieved OR after transarterial radioembolization (TARE) had a significantly longer median OS of 17 months compared with patients that did not who survived a median of 10 months (p=0.03). Response was landmarked at 2 months after TARE, since response status was not known until the first follow-up PET/CT. The analysis includes patients with imaging response assessment who were followed for at least 2 months (n=58).